These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1095 related items for PubMed ID: 30125988

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Unique metastasis-associated lncRNA signature optimizes prediction of tumor relapse in lung adenocarcinoma.
    Zhang X, Han J, Du L, Li X, Hao J, Wang L, Zheng G, Duan W, Xie Y, Zhao Y, Zhang X, Zou M, Wang C.
    Thorac Cancer; 2020 Mar; 11(3):728-737. PubMed ID: 31994347
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Development of a novel prognostic signature of long non-coding RNAs in lung adenocarcinoma.
    Zheng S, Zheng D, Dong C, Jiang J, Xie J, Sun Y, Chen H.
    J Cancer Res Clin Oncol; 2017 Sep; 143(9):1649-1657. PubMed ID: 28409273
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Relapse-related long non-coding RNA signature to improve prognosis prediction of lung adenocarcinoma.
    Zhou M, Xu W, Yue X, Zhao H, Wang Z, Shi H, Cheng L, Sun J.
    Oncotarget; 2016 May 17; 7(20):29720-38. PubMed ID: 27105492
    [Abstract] [Full Text] [Related]

  • 10. A Seven-Gene Signature with Close Immune Correlation Was Identified for Survival Prediction of Lung Adenocarcinoma.
    Zou X, Hu Z, Huang C, Chang J.
    Med Sci Monit; 2020 Jul 02; 26():e924269. PubMed ID: 32613949
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Differential expression analysis at the individual level reveals a lncRNA prognostic signature for lung adenocarcinoma.
    Peng F, Wang R, Zhang Y, Zhao Z, Zhou W, Chang Z, Liang H, Zhao W, Qi L, Guo Z, Gu Y.
    Mol Cancer; 2017 Jun 06; 16(1):98. PubMed ID: 28587642
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A novel seven-long non-coding RNA signature predicts survival in early stage lung adenocarcinoma.
    Chen M, Liu B, Xiao J, Yang Y, Zhang Y.
    Oncotarget; 2017 Feb 28; 8(9):14876-14886. PubMed ID: 28122330
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Potential Prognostic Biomarkers of Lung Adenocarcinoma Based on Bioinformatic Analysis.
    Hou J, Yao C.
    Biomed Res Int; 2021 Feb 28; 2021():8859996. PubMed ID: 33511215
    [Abstract] [Full Text] [Related]

  • 20. Development of m6A/m5C/m1A regulated lncRNA signature for prognostic prediction, personalized immune intervention and drug selection in LUAD.
    Ma C, Gu Z, Yang Y.
    J Cell Mol Med; 2024 Apr 28; 28(8):e18282. PubMed ID: 38647237
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.